[Congressional Record Volume 163, Number 7 (Wednesday, January 11, 2017)]
[Senate]
[Page S285]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 128. Ms. WARREN submitted an amendment intended to be proposed by 
her to the concurrent resolution S. Con. Res. 3, setting forth the 
congressional budget for the United States Government for fiscal year 
2017 and setting forth the appropriate budgetary levels for fiscal 
years 2018 through 2026; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO 
                   SUPPORTING EFFORTS OF THE FOOD AND DRUG 
                   ADMINISTRATION TO IMPROVE POSTMARKET DEVICE 
                   SURVEILLANCE AND TO INCLUDE DEVICE IDENTIFIER 
                   INFORMATION IN MEDICAL CLAIMS FORMS.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution 
     for one or more bills, joint resolutions, amendments, 
     amendments between the Houses, motions, or conference reports 
     relating to supporting efforts of the Food and Drug 
     Administration to improve postmarket device surveillance and 
     to include device identifier information in medical claims 
     forms by the amounts provided in such legislation for those 
     purposes, provided that such legislation would not increase 
     the deficit over either the period of the total of fiscal 
     years 2017 through 2021 or the period of the total of fiscal 
     years 2017 through 2026.
                                 ______